• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

OKYO Pharma Limited - Ordinary Shares (NQ:OKYO)

2.790 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about OKYO Pharma Limited - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >
OKYO Pharma Receives $1.9 Million in Non-Dilutive Funding to Accelerate Development of Urcosimod for Neuropathic Corneal Pain
July 17, 2025
From OKYO Pharma LTD
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 17, 2025
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
July 16, 2025
Via Benzinga
3 Health Care Stocks Moving In Thursday's Intraday Session
October 24, 2024
Via Benzinga
OKYO Pharma Unveils Strong Phase 2 Clinical Trial Results for Urcosimod to Treat Neuropathic Corneal Pain
July 16, 2025
From OKYO Pharma LTD
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 15, 2025
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
June 16, 2025
Via Benzinga
Goldman Small Cap Research Issues New Research Update on OKYO Pharma Limited
June 11, 2025
Via ACCESS Newswire
OKYO Pharma to Present at the Bio International Convention
June 11, 2025
From OKYO Pharma LTD
Via GlobeNewswire
OKYO Pharma to Present at the GPCRs-Targeted Drug Discovery Summit
May 19, 2025
From OKYO Pharma LTD
Via GlobeNewswire
FDA Grants OKYO Pharma Fast Track Designation to Urcosimod for Neuropathic Corneal Pain
May 01, 2025
From OKYO Pharma LTD
Via GlobeNewswire
OKYO Pharma Announces Plans to Accelerate the Clinical Development of Urcosimod to Treat Neuropathic Corneal Pain
April 30, 2025
From OKYO Pharma LTD
Via GlobeNewswire
OKYO Pharma Announces Positive Data in Long-Term Stability of Urcosimod
March 31, 2025
From OKYO Pharma LTD
Via GlobeNewswire
OKYO Pharma Files for Fast Track Designation with FDA for Urcosimod to Treat Neuropathic Corneal Pain
March 10, 2025
From OKYO Pharma LTD
Via GlobeNewswire
OKYO Pharma Announces OK-101 Officially Assigned USAN : Urcosimod
February 12, 2025
From OKYO Pharma LTD
Via GlobeNewswire
OKYO Pharma Announces Chairman and CEO Acquire Shares
January 31, 2025
From OKYO Pharma LTD
Via GlobeNewswire
Goldman Small Cap Research Publishes New Research Report on OKYO Pharma Limited
January 30, 2025
Via ACCESS Newswire
OKYO Pharma to Complete Enrollment of Neuropathic Corneal Pain Trial by End of Second Quarter
January 29, 2025
From OKYO Pharma LTD
Via GlobeNewswire
OKYO Pharma Receives $1.4 Million in Non-Dilutive Funding
January 22, 2025
From OKYO Pharma LTD
Via GlobeNewswire
OKYO Pharma to Participate at the 4th Annual BTIG Ophthalmology Conference
November 26, 2024
From OKYO Pharma LTD
Via GlobeNewswire
MUSQ Global Music Industry ETF and OKYO Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
November 15, 2024
Via ACCESSWIRE
OKYO Pharma to Present at International Tear Film and Ocular Surface Society Conference
October 30, 2024
From OKYO Pharma LTD
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
October 25, 2024
Via Benzinga
OKYO Pharma Announces First Patient Dosed in the First Clinical Trial to Treat Neuropathic Corneal Pain
October 23, 2024
From OKYO Pharma LTD
Via GlobeNewswire
OKYO Pharma Announces Start of Phase 2 Clinical Trial to Treat Patients with Neuropathic Corneal Pain
October 16, 2024
From OKYO Pharma LTD
Via GlobeNewswire
OKYO Pharma Announces Chairman Acquires Shares
September 10, 2024
From OKYO Pharma LTD
Via GlobeNewswire
OKYO Pharma Announces Chairman Acquires Shares
September 05, 2024
From OKYO Pharma LTD
Via GlobeNewswire
OKYO Pharma Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease
August 27, 2024
From OKYO Pharma LTD
Via GlobeNewswire
Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
August 26, 2024
Via Benzinga
OKYO Pharma CEO Interview to Air on Bloomberg TV
August 23, 2024
From OKYO Pharma LTD
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap